Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viral vectors in neurodegenerative diseases: immune responses and therapeutic applications

18 Jun 2025

Abstract excerpt

Gene transfer-based therapies utilizing viral vectors have undergone remarkable advancements and hold significant promise in addressing neurodegenerative diseases in recent years, whose potential mechanisms include replacing or silencing pathogenic genes and delivering neurotrophic factors. Current preclinical research focuses on developing novel strategies in gene modification to combat neurodegenerative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to RNA Interference and Gene Delivery
Share to Viral Infections and Immunology Research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40606141
DOI: 10.3389/fneur.2025.1603125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viral vectors in neurodegenerative diseases: immune responses and therapeutic applicationsPMID 40606141Read ↗

Viral gene delivery vectors: the next generation medicines for immune-related diseasesSemantic proximity Read ↗

Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseasesSemantic proximity Read ↗

Applications of adeno-associated virus vector-mediated gene delivery for neurodegenerative diseases and psychiatric diseases: Progress, advances, and challengesSemantic proximity Read ↗

Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous SystemSemantic proximity Read ↗

Immune Responses and Immunosuppressive Strategies for Adeno-Associated Virus-Based Gene Therapy for Treatment of Central Nervous System Disorders: Current Knowledge and ApproachesSemantic proximity Read ↗

HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part II. Vector Systems and ApplicationsSemantic proximity Read ↗

Immune Responses to Adenovirus and Adeno-Associated Vectors Used for Gene Therapy of Brain Diseases: The Role of Immunological Synapses in Understanding the Cell Biology of Neuroimmune InteractionsSemantic proximity Read ↗

Viral vectors for gene delivery to the central nervous systemSemantic proximity Read ↗

Targeting microglia with lentivirus and AAV: Recent advances and remaining challengesSemantic proximity Read ↗

Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseasesSemantic proximity Read ↗

Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disordersSemantic proximity Read ↗

Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedsideSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.